Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aleglitazar crossover study of cardiac energetics in uncomplicated type 2 diabetes
2012-001639-29Phase 2Terminated
- Sponsor
- Roche
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of aleglitazar in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Roche. Started May 2012; status: terminated.
02
Drugs
aleglitazar
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-001639-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001639-29.